Characterization of the interaction between hydroxypropyl guar galactomannan and galectin-3

Biochemical and Biophysical Research Communications

Volumn 424, Issue 1, 2012, Pages 12-17

  Woodward, Ashley M ^a   Senchyna, Michelle ^b,c   Williams, Ravaughn ^b   Argüeso, Pablo ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b ALCON RESEARCH LTD   (United States)

^c PanOptica Inc   (United States)

Author keywords

Corneal keratinocytes; Galectin 3; Glycocalyx; Hydroxypropyl guar galactomannan; MUC16

Indexed keywords

ECALECTIN; GALACTOMANNAN; GALACTOSE; GALECTIN 3; GALECTIN 8; HYDROXYPROPYL GUAR GALACTOMANNAN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BIOTINYLATION; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CORNEA CELL; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION;

CA-125 ANTIGEN; CELL LINE; CORNEA; GALACTOSE; GALECTIN 3; HUMANS; KERATINOCYTES; MANNANS; MEMBRANE PROTEINS;

CYAMOPSIS TETRAGONOLOBA;

EID: 84864089368     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.160     Document Type: Article

References (35)

1. Gornik O., Dumic J., Flogel M., Lauc G. Glycoscience - a new frontier in rational drug design. Acta Pharm. 2006, 56:19-30.
2. Roy R. Syntheses and some applications of chemically defined multivalent glycoconjugates. Curr Opin Struct Biol. 1996, 6:692-702.
3. David A., Kopeckova P., Rubinstein A., Kopecek J. Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells. Bioconjuateg Chem. 2001, 12:890-899.
4. Oppenheimer S.B., Alvarez M., Nnoli J. Carbohydrate-based experimental therapeutics for cancer, HIV/AIDS and other diseases. Acta Histochem 2008, 110:6-13.
5. Giannini E.G., Mansi C., Dulbecco P., Savarino V. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition 2006, 22:334-342.
6. Springs C.L. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye. Adv Ther 2010, 27:681-690.
7. Kaushik D., Sardana S., Mishra D.N. 5-fluorouracil loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro release. Yao Xue Xue Bao 2009, 44:1278-1284.
8. Sharon N., Lis H. Lectins as cell recognition molecules. Science 1989, 246:227-234.
9. Barondes S.H., Castronovo V., Cooper D.N., Cummings R.D., Drickamer K., Feizi T., Gitt M.A., Hirabayashi J., Hughes C., Kasai K., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994, 76:597-598.
10. Demetter P., Nagy N., Martin B., Mathieu A., Dumont P., Decaestecker C., Salmon I. The galectin family and digestive disease. J Pathol 2008, 215:1-12.
11. Gunning A.P., Bongaerts R.J., Morris V.J. Recognition of galactan components of pectin by galectin-3. FASEB J 2009, 23:415-424.
12. David A., Kopeckova P., Minko T., Rubinstein A., Kopecek J. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer 2004, 40:148-157.
13. Miller M.C., Klyosov A., Mayo K.H. The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain. Glycobiology 2009, 19:1034-1045.
14. Lagana A., Goetz J.G., Cheung P., Raz A., Dennis J.W., Nabi I.R. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol. Cell. Biol. 2006, 26:3181-3193.
15. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., Nabi I.R., Wrana J.L., Dennis J.W. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306:120-124.
16. Argueso P., Guzman-Aranguez A., Mantelli F., Cao Z., Ricciuto J., Panjwani N. Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. J. Biol. Chem. 2009, 284:23037-23045.
17. Arnosti C. Measurement of depth- and site-related differences in polysaccharide hydrolysis rates in marine sediments. Geochimica et Cosmochimica Acta 1995, 59:4247-4257.
18. Argueso P., Gipson I.K. Quantitative analysis of mucins in mucosal secretions using indirect enzyme-linked immunosorbent assay. Methods Mol Biol 2006, 347:277-288.
19. Gipson I.K., Spurr-Michaud S., Argueso P., Tisdale A., Ng T.F., Russo C.L. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 2003, 44:2496-2506.
20. Yi S.M., Harson R.E., Zabner J., Welsh M.J. Lectin binding and endocytosis at the apical surface of human airway epithelia. Gene Ther. 2001, 8:1826-1832.
21. Xiong L., Woodward A.M., Argueso P. Notch signaling modulates MUC16 biosynthesis in an in vitro model of human corneal and conjunctival epithelial cell differentiation. Invest Ophthalmol Vis Sci 2011, 52:5641-5646.
22. Mantelli F., Schaffer L., Dana R., Head S.R., Argueso P. Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling. Invest Ophthalmol Vis Sci 2009, 50:2666-2672.
23. Prabaharan M. Prospective of guar gum and its derivatives as controlled drug delivery systems. Int. J. Biol. Macromol. 2011, 49:117-124.
24. Miller M.C., Nesmelova I.V., Platt D., Klyosov A., Mayo K.H. The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface. Biochem. J 2009, 421:211-221.
25. Miller M.C., Klyosov A., Mayo K.H. Structural Features for alpha-galactomannan binding to galectin-1. Glycobiology 2012, 22:543-551.
26. Song X., Xia B., Stowell S.R., Lasanajak Y., Smith D.F., Cummings R.D. Novel fluorescent glycan microarray strategy reveals ligands for galectins. Chem. Biol. 2009, 16:36-47.
27. Stowell S.R., Arthur C.M., Mehta P., Slanina K.A., Blixt O., Leffler H., Smith D.F., Cummings R.D. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 2008, 283:10109-10123.
28. Poland P.A., Rondanino C., Kinlough C.L., Heimburg-Molinaro J., Arthur C.M., Stowell S.R., Smith D.F., Hughey R.P. Identification and characterization of endogenous galectins expressed in Madin Darby canine kidney cells. J. Biol. Chem. 2011, 286:6780-6790.
29. Ubels J.L., Clousing D.P., Van Haitsma T.A., Hong B.S., Stauffer P., Asgharian B., Meadows D. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent. Curr Eye Res 2004, 28:437-444.
30. Christensen M.T., Cohen S., Rinehart J., Akers F., Pemberton B., Bloomenstein M., Lesher M., Kaplan D., Meadows D., Meuse P., Hearn C., Stein J.M. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res 2004, 28:55-62.
31. Mussoline J.F. Systane for dry eye: Letters. Cataract & Refractive Surgery Today 2004, 14-16.
32. Kolatsi-Joannou M., Price K.L., Winyard P.J., Long D.A. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury. PLoS One 2011, 6:e18683.
33. Katav T., Liu L., Traitel T., Goldbart R., Wolfson M., Kost J. Modified pectin-based carrier for gene delivery: cellular barriers in gene delivery course. J. Controlled Release 2008, 130:183-191.
34. Glinsky V.V., Raz A. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. Carbohydr. Res. 2009, 344:1788-1791.
35. Duncan R., Seymour L.C., Scarlett L., Lloyd J.B., Rejmanova P., Kopecek J. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim. Biophys. Acta 1986, 880:62-71.